- Document[18].pdfuploaded bySilvy
- DocumentLama Hari Rawatuploaded bySilvy
- DocumentHealth Research Methodology WHO 2004.pdfuploaded bySilvy
- DocumentHasil Riskesdas 2013.pdfuploaded bySilvy
- DocumentCHI-KUADRAT.pdfuploaded bySilvy
- DocumentJurnal 1uploaded bySilvy
- DocumentEdisi Jurnal 7.en.iduploaded bySilvy
- DocumentGlucose 5 Aviva_piuploaded bySilvy
- Documentdr.-Fiva-Kompatibilitas-dan-Inkompatibilitas-Obat-di-NICU.pdfuploaded bySilvy
- Document5 Kunci Kp Untuk Keluarga (1)uploaded bySilvy
- Document4_FARMAKODINAMIKA.pdfuploaded bySilvy
- Document4-5-17.1 (1).pdfuploaded bySilvy
- Document3. Pharmacokinetics.pptuploaded bySilvy
- Document2.pdfuploaded bySilvy
- Document3.2 FTIR.docxuploaded bySilvy
- Document4-5-17.1 (1)uploaded bySilvy
- Document3.2 FTIR.docxuploaded bySilvy
- Document1.pdfuploaded bySilvy
- Document2uploaded bySilvy
- Document[18].pdfuploaded bySilvy
- Document112651_lipophylicity - Methods of Determination and Its Role in Medicinal Chemistry.en.Iduploaded bySilvy
- DocumentAir Minuman Reverse Osmosis.pptuploaded bySilvy
- Document209765590-Epidemiologi-Nyeri.pdfuploaded bySilvy
- Document3. TOXICANT PROCESSING IN VIVO.pptxuploaded bySilvy
- Document222095227-ABSORBSI-pptuploaded bySilvy
- DocumentDrug Development Ttm-2uploaded bySilvy
- Document3. TOXICANT PROCESSING IN VIVO.pptxuploaded bySilvy
- Document1-1-7-1-10-20170220.pdfuploaded bySilvy
- Document1.pdfuploaded bySilvy
- DocumentMedical Abbreviations used by Hospital Professionals.docuploaded bySilvy
- Document3.2 FTIRuploaded bySilvy
- Documenthindawi jurnal.pdfuploaded bySilvy
- DocumentAir Minuman Reverse Osmosisuploaded bySilvy
- Document3. Pharmacokineticsuploaded bySilvy
- DocumentAplikasi_Cek_BPOM.pptuploaded bySilvy
- Document1.pdfuploaded bySilvy
- Document78-176-1-SMuploaded bySilvy
- Document721-1787-1-SM (1).pdfuploaded bySilvy
- Document1. Bioavailability and Boequivalence.pptuploaded bySilvy
- DocumentReview on Mucoadhesive Drug Delivery System With Special Emphasis Onbuccal Route an Important Tool in Designing of Novel Controlled 2329 6631 1000169uploaded bySilvy
- Document1-Vol.1-Issue-9-Sep-2014-RE-128-Paper-1.pdfuploaded bySilvy
- Document1. Bioavailability and Boequivalence.en.id.pptuploaded bySilvy
- Documentbiosintesisdanmetabolismeprodukalami-161022093858.pdfuploaded bySilvy
- Document1-7.pdfuploaded bySilvy
- Document1uploaded bySilvy
- Document[18].pdfuploaded bySilvy
- Document[18]uploaded bySilvy
- DocumentPermenperind_No.23_2013_1.pdfuploaded bySilvy
- DocumentPain Assessment.en.id.docxuploaded bySilvy